click enter text
better fear agil call acceler china growth modest
 declin flag optim rel think dgg surpris
upsid european patholog insul flat vs expect
acad-gov end market sourc pressur though posit
compar less week us/emea lab shutdown given
covid research like remain challeng agil gave guidanc
 organ growth midpoint bracket pre-earn
forecast lower bound assum slow reopen us/eu
flattish china recoveri hardwar trend compar favor tmo/wat
trend vs agil lessen
exposur test tailwind revenu rnax
reduc scope expans balanc benefici exposur
good quarter
expect forward trend continu vet
 uncertainti persist organ vs pre-
earn estim mix chemicals-energi management
acknowledg sustain pressur petrochem energi capital-expenditure
point increment favor time replac cycl outlook
similar perform delin threat scarc
take agil exit qtr growth april see earli sign
similar yoy growth may agil save sg
save next agil shutter lasergen intend
platform tough competit environ re-distribut
annual spend elsewher robust china recoveri yoy exit
growth april posit tool china lab exposur balanc us/eu
dd april agil cut capital-expenditure save
pharma/biotech insul nasd continu grow
despit fear clinic trial delay therapeut pipelin
tailwind potenti
trade fundament data
upsid target
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
exhibit varianc estim
exhibit agil offer median return sinc wuhan
page
mnorgan estimate ep gross inc inc net incom ep bpstax net industri medtechhealthcar ls tool ilmntools/sector stock return growth adj analysi organ food growth wr sm lsag non-china pharma cell line ex ex calc
page
